Overview

A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Vancomycin or Metronidazole is safe and beneficial in the treatment of Primary Sclerosing Cholangitis.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
PSC Partners Seeking a Cure Foundation
Treatments:
Metronidazole
Vancomycin